SG3 Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$781K | – | 421 |
|
|
2022
Q1 | $781K | Buy |
10,000
+6,500
| +186% | +$508K | 0.02% | 78 |
|
|
2021
Q4 | $315K | Sell |
3,500
-5,500
| -61% | -$495K | 0.01% | 174 |
|
|
2021
Q3 | $832K | Buy |
+9,000
| New | +$832K | 0.03% | 78 |
|
|
2021
Q2 | – | Sell |
-14,000
| Closed | -$1.04M | – | 653 |
|
|
2021
Q1 | $1.04M | Buy |
14,000
+11,000
| +367% | +$820K | 0.03% | 89 |
|
|
2020
Q4 | $511K | Sell |
3,000
-1,000
| -25% | -$170K | 0.01% | 127 |
|
|
2020
Q3 | $562K | Buy |
4,000
+2,500
| +167% | +$351K | 0.02% | 92 |
|
|
2020
Q2 | $241K | Buy |
+1,500
| New | +$241K | 0.02% | 107 |
|
|
2019
Q1 | – | Sell |
-5,000
| Closed | -$546K | – | 230 |
|
|
2018
Q4 | $546K | Buy |
+5,000
| New | +$546K | 0.14% | 14 |
|
|
2017
Q4 | – | Sell |
-3,500
| Closed | -$159K | – | 119 |
|
|
2017
Q3 | $159K | Buy |
+3,500
| New | +$159K | 0.04% | 29 |
|